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Abstract 
 
Using data from The Health Improvement Network and Hospital Episode 
Statistics we investigate smoking prevalence, number of smokers treated, 
and opportunities for cessation intervention among patients treated in 
NHS hospitals in England from April 2010 to March 2011. Our results show 
that approximately 1.1 million smokers are treated in English hospitals 
each year, receiving a total of 2.6 million episodes of care. These findings 
suggest that delivering smoking cessation as a routine component of 
hospital care, as recommended by recent NICE guidance, could achieve 
marked reductions in the prevalence of smoking and improve the cost-
effectiveness of NHS hospitals. 
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Introduction 
Smoking was responsible for over 460,000 adult admissions to National 
Health Service (NHS) hospitals in England in the year to March 2012, and 
treating diseases caused by smoking cost the NHS over £5 billion, about 
5% of its annual budget, in the 2005-6 financial year1. Since smoking is 
entirely preventable and treatable, many hospital admissions represent an 
avoidable drain on scarce financial and wider NHS resources.   
 
Treating smoking should be a high priority in the delivery of NHS services, 
however, the proportion of smokers who receive treatment for smoking 
from the NHS each year is extremely low and falling2. Contrary to Domain 
1 of the NHS Outcomes Framework to prevent people dying prematurely, 
this low engagement with smokers represents a failure by the NHS to 
treat the biggest avoidable cause of disease, death, and social inequality 
in health, in the UK. Since delivering smoking cessation interventions in 
secondary care is highly cost-effective3, it also reflects a failure to manage 
NHS budgets effectively by prioritising the most cost-effective activities.  
 
Guidance issued by the National Institute for Health and Care Excellence 
(NICE) in 2013 recommended the routine and systematic delivery of 
cessation support to all smokers using secondary care services3. However, 
the prevalence of smoking among those treated in NHS hospitals, and 
hence the number of people who might benefit, is unknown. This audit 
was therefore designed to estimate the prevalence of smoking among 
NHS hospital inpatients in England, the number of smokers treated and 
the number of potential opportunities for smoking cessation, by treatment 
speciality in the year 2010-11.  
 
Methods 
We identified all patients aged 15 and over who were registered with one 
of 72 general practices contributing to the Health Improvement Network 
(THIN) database for the year from 1st April 2010 to 31st March 2011, and 
used linked Hospital Episode Statistics (HES) data to determine who of 
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these experienced one or more finished consultant episodes (FCEs) of 
hospital care. For those with more than one FCE during the study year we 
selected an episode at random, identified the treatment specialty, and 
took the admission date of the FCE as the index date on which to assess 
smoking status. For patients with no FCEs we assigned a random index 
date during the study year.  
 
Smoking status at the index date (current, ex, never or unknown) was 
taken to be the most recent recorded in the GP record, up to 27 months 
before this date, in line with the Quality and Outcomes Framework (QOF) 
requirement for GPs to ascertain smoking status in all patients aged 15 
and over at least once every 27 months. Since the QOF gives practices 90 
days in which to record the smoking status of new patients, we excluded 
any patients who at the index date had less than 90 days of recorded GP 
data.  
 
We quantified the proportions of current and ex-smokers among patients 
who did and did not have an FCE during the study period, and among 
those who did, by clinical specialty of the index FCE. To account for 
demographic differences between patients treated in each speciality we 
calculated the relative odds and 95% confidence intervals (CIs) of being a 
current smoker among those treated in any given speciality and overall, 
compared to those without an FCE, with adjustment for age and sex.  
 
We used our prevalence estimates and Office for National Statistics mid-
2010 national population data to estimate the number of smokers aged 
15+ treated as inpatients in 2010/11 in England as a whole. Finally we 
used data on the number of FCEs in England by speciality4 for patients 
aged 15+ in 2010/11 to estimate the number of FCEs nationally in which 
the patient was a current or ex-smoker and thereby the number of 
opportunities for delivering cessation interventions.  
 
Data analysis was carried out using Stata 12 (Stata Corp, College Station, 
TX). Ethics approval was granted by the THIN Scientific Review 
Committee (ref. 12-025). 
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Results 
There were 551,320 patients aged 15+ registered in the 72 practices in 
the study year; we excluded 1,342 patients with less than 90 days’ data 
before their index date. Of those remaining, 80,007 (14.5%) experienced 
172,537 FCEs in total delivered over 151,342 inpatient spells. Of patients 
treated in hospital, 66.9% had just one inpatient spell during the study 
year, 19.4% had two, and 13.7% had three or more. 
 
A record of smoking status was available for 61.4% of patients without an 
FCE and 74.4% of patients with one or more. Of patients with no FCE in 
the study year, 14.7% were current and 19.8% ex-smokers; in those with 
at least one FCE, these figures were 17.0% and 30.2% respectively. When 
compared by treatment specialty the prevalence of ever (current or ex) 
smoking was generally similar across all specialties but highest in those 
treated for mental illness; however, the prevalence of current smoking 
was over twice as high in those with mental illness compared to other 
specialities. The age and sex-adjusted odds of being a current smoker, 
relative to those not treated in hospital, were increased by a ratio of 1.36 
(95% CI 1.33 to 1.39, p<0.001) among those with any FCE but also 
varied substantially according to treatment specialty (Table 1).  
 
Extrapolation of our prevalence data to the total number of FCEs in 
England in the study year suggests that approximately 2.6 million 
episodes of care were delivered to current smokers in 2010-11. There 
were an estimated 43,318,368 people aged 15+ in England in mid-2010, 
and extrapolating our estimates that 14.5% of these were treated as a 
hospital inpatient, and that 17% of patients were smokers, indicates that 
during the study period approximately 2.6 million episodes of care were 
delivered to approximately 1.1 million individual smokers.    
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Table 1: Smoking status by speciality, adjusted ORs relative to 
patients not treated, and estimated number of national FCEs for 
patients aged 15+ in England in 2010/11 in current and ex-
smokers (ranked by % current smokers) 
 
Speciality	
Number	
of	
patients	
in	study	
dataset	
%	
current	
smokers	
%	ex	
smokers	
Adjusted	OR	for	current	
smoking,	95%	CI,	
p	valuea	
Total	
number	of	
FCEs	in	
patients	
aged	15+b	
Number	
of	
episodes	
where	
patient	
current	
smokerc	
Number	
of	
episodes	
where	
patient	
ex-
smokerd	
Not	admitted	 469,971	 14.7	 19.8	 Baseline	 	 	 	
Admitted	 80,007	 17.0	 30.2	 1.36	(1.33-1.39)	p<0.001	 15,218,526	 2,591,869	 4,590,267	
	 	 	 	 	 	 	 	
Adult	mental	illness	 472	 51.7	 10.6	 5.40	(4.50-6.48)	p<0.001	 121,363	 62,739	 12,856	
Neurology	 435	 23.2	 28.0	 1.83	(1.46-2.29)	p<0.001	 110,457	 25,646	 30,979	
Oral	surgery	 1,501	 22.3	 20.7	 1.55	(1.37-1.75)	p<0.001	 185,189	 41,208	 38,247	
Thoracic	medicine	 1,178	 21.9	 37.4	 2.06	(1.79-2.37)	p<0.001	 328,631	 71,975	 122,748	
Neurosurgery	 514	 21.6	 28.6	 1.71	(1.39-2.12)	p<0.001	 79,511	 17,171	 22,740	
Pain	management	 880	 21.6	 29.3	 1.88	(1.60-2.21)	p<0.001	 	 	 	
Accident	&	emergency	 3,320	 21.5	 26.5	 1.80	(1.65-1.96)	p<0.001	 616,188	 132,703	 163,141	
Ear,	nose	and	throat	 2,076	 21.5	 25.3	 1.64	(1.47-1.82)	p<0.001	 255,163	 54,818	 64,651	
Vascular	surgery	 440	 20.5	 38.2	 1.88	(1.49-2.37)	p<0.001	 	 	 	
Upper	GI	surgery	 402	 20.4	 31.1	 1.64	(1.28-2.10)	p<0.001	 	 	 	
Gynaecology	 5,089	 20.1	 21.8	 1.32	(1.23-1.41)	p<0.001	 1,023,518	 205,548	 222,845	
Maxillo-facial	surgery	 718	 18.8	 24.2	 1.40	(1.16-1.70)	p<0.001	 	 	 	
General	medicine	 12,343	 18.7	 32.8	 1.67	(1.59-1.75)	p<0.001	 2,807,520	 523,609	 920,752	
Obstetrics	 4,960	 18.6	 24.8	 0.98	(0.92-1.06)	p=0.667	 751,316	 139,963	 186,163	
General	surgery	 9,433	 18.3	 29.1	 1.46	(1.39-1.54)	p<0.001	 1,704,643	 312,449	 496,412	
Clinical	oncology	 433	 16.9	 33.9	 1.49	(1.16-1.92)	p=0.002	 346,188	 58,364	 117,528	
Midwifery	 1,803	 16.1	 23.6	 0.81	(0.72-0.92)	p=0.001	 263,599	 42,398	 62,281	
Gastroenterology	 5,182	 16.0	 32.0	 1.31	(1.22-1.41)	p<0.001	 755,762	 120,759	 241,809	
Plastic	surgery	 1,713	 15.7	 28.5	 1.20	(1.05-1.37)	p=0.006	 216,779	 34,042	 61,883	
Urology	 4,731	 15.1	 35.5	 1.28	(1.18-1.39)	p<0.001	 791,324	 119,259	 281,170	
Trauma	&	orthopaedics	 10,170	 14.9	 28.7	 1.18	(1.12-1.25)	p<0.001	 1,118,975	 167,021	 320,619	
Medical	oncology	 430	 14.9	 33.7	 1.32	(1.01-1.73)	p=0.041	 212,779	 31,669	 71,751	
Colorectal	surgery	 1,122	 14.3	 33.5	 1.16	(0.98-1.37)	p=0.088	 	 	 	
Rheumatology	 553	 14.1	 31.6	 1.17	(0.92-1.48)	p=0.216	 147,583	 20,816	 46,703	
Nephrology	 405	 14.1	 38.0	 1.21	(0.91-1.60)	p=0.189	 159,858	 22,499	 60,786	
Breast	surgery	 475	 13.9	 25.9	 1.09	(0.84-1.41)	p=0.533	 	 	 	
Dermatology	 944	 13.1	 32.9	 1.14	(0.94-1.38)	p=0.178	 115,950	 15,231	 38,200	
Cardiology	 3,715	 13.1	 41.3	 1.18	(1.07-1.30)	p=0.001	 571,086	 74,556	 236,121	
Clinical	haematology	 669	 11.7	 33.3	 0.97	(0.77-1.23)	p=0.822	 396,215	 46,195	 132,072	
Geriatric	medicine	 2,044	 11.2	 35.3	 1.10	(0.95-1.26)	p=0.197	 719,805	 80,644	 254,256	
Ophthalmology	 4,586	 9.0	 39.9	 0.85	(0.77-0.94)	p=0.002	 611,203	 55,043	 244,161	
 
a Adjusted for sex and age group (15-19, 20-24, 25-34, 35-49, 50-59, 60+)   
b Data not available for all treatment specialities 
c Calculated as total number of FCEs for speciality x prevalence of current smoking for speciality 
d Calculated as total number of FCEs for speciality x prevalence of ex smoking for speciality 
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Discussion 
This study demonstrates that each year in England around 2.6 million 
episodes of inpatient care are delivered to approximately 1.1 million 
smokers. At an individual and population level, intervening to maximise 
the number of smokers who receive effective NHS support to stop 
smoking as part of their hospital care represents an opportunity for both 
health promotion and cost management through a reduction in demand 
on NHS services. This is particularly true of people treated in mental 
health settings, among whom current smoking rates are double those in 
other specialities.  
 
The THIN dataset is broadly representative of the UK population and 
estimates of the prevalence of current smoking from THIN are comparable 
to those derived from national survey data5, adding credibility to our 
estimates of the burden of smoking and opportunities for intervention at a 
national level.   
 
NHS Stop Smoking Services (SSS) provide freely available behavioural 
support and pharmacotherapy, but these services are predominantly 
community-based and hence not immediately available to smokers 
admitted to or discharged from hospital. Separate funding streams for 
community and hospital services mitigate against service integration, 
since both services can argue that the other is responsible for inpatient 
smoking cessation provision. Our own recent trial data demonstrate that 
treating smoking as a default at the point of admission substantially 
increases the proportion of smokers accepting support6, and this approach 
is now recommended in NICE guidance3 and the British Thoracic Society’s 
Recommendations for Hospital Smoking Cessation Services7. The findings 
of the present study indicate that default provision of behavioural support 
and pharmacotherapy to smokers treated as inpatients in English hospitals 
has the potential to reach 1.1 million smokers each year. NICE data 
indicate that this approach is cost-effective for both hospitals and wider 
society3. The routine provision of smoking cessation support to smokers 
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seen as outpatients, not captured in this study of inpatient data, will 
further increase the number of smokers reached. Indeed, HES outpatient 
data indicate 61.5 million outpatient appointments were attended by 
patients aged 20+ in England in the 2010-11 financial year, approximately 
four times the number of inpatient FCEs, substantially increasing the 
number of opportunities to intervene with smokers4. 
 
Our finding that around 47% of people treated in hospital are current or 
ex-smokers, compared with about 35% of those not treated, is broadly 
consistent with the strong role that smoking plays in causing disease, 
particularly respiratory and cardiovascular disease. However, the 
proportion of hospital patients who had quit smoking was also generally 
high, at around two thirds, and broadly similar between specialties, with 
the exception of mental illness. Over 60% of people treated for mental 
illness were ever-smokers and 50% were current smokers. People with 
mental health problems are more likely to be smokers and to be more 
heavily addicted, but the extraordinarily high prevalence of continued 
smoking in this group reflects the previously highlighted failure of existing 
approaches to engage with this patient group.  
 
Our study thus identifies both the importance, and the magnitude of the 
opportunity to intervene to treat smokers and reduce the prevalence of 
smoking in NHS secondary care users. Implementation of current NICE 
guidance to deliver smoking cessation interventions as a routine 
component of secondary care provision could have a major impact on the 
prevalence of smoking, and hence on the morbidity and mortality that 
smoking causes.  
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